• OPEN AN ACCOUNT
Indian Indices
Sensex
72,472.33 879.09
( 1.23%)
Global Indices
Nasdaq
51,671.07 418.43
(0.82%)
Dow Jones
7,831.57 45.21
(0.58%)
Hang Seng
69,084.74 42.63
(0.06%)
Nikkei 225
10,559.70 118.10
(1.13%)
Forex
USD-INR
96.78 0.11
(0.12%)
EUR-INR
108.39 0.07
(0.07%)
GBP-INR
127.86 0.00
(0.00%)
JPY-INR
0.61 0.00
(0.21%)

EQUITY - MARKET SCREENER

Gufic BioSciences Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
509079
INE742B01025
66.2311355
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
GUFICBIO
55.23
4059.44
EPS(TTM)
Face Value()
Div & Yield %
7.33
1
0.02
 

genpharmasec limited
Continental Controls reports standalone net loss of Rs 0.04 crore in the March 2026 quarter
Apr 15,2026
Net Loss of Continental Controls reported to Rs 0.04 crore in the quarter ended March 2026 as against net loss of Rs 0.01 crore during the previous quarter ended March 2025. There were no Sales reported in the quarter ended March 2026 and during the previous quarter ended March 2025.

For the full year,net loss reported to Rs 0.13 crore in the year ended March 2026 as against net profit of Rs 0.07 crore during the previous year ended March 2025. There were no Sales reported in the year ended March 2026 and during the previous year ended March 2025.